Wordt geladen...

Arsenic trioxide for the treatment of acute promyelocytic leukaemia

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the role of arsenic trioxide (ATO) for treating patients with acute promyelocytic leukaemia in comparison with regimens without ATO.

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cochrane Database Syst Rev
Hoofdauteurs: Xu, ShuangNian, Chen, JiePing, Liu, Jian Ping, Xia, Yun, Li, Xi, Tan, Ya
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley & Sons, Ltd 2016
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6463851/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD008425.pub2
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!